14 MARCH

NEW ZEALAND GAZETTE

643

Private Bills

The Royal New Zealand Foundation of the Blind Bill 2002

Royal New Zealand Foundation for the Blind Act 1963

The Royal New Zealand Foundation of the Blind Bill 2002

Notice of Intention to Promote a Private Bill

The Royal New Zealand Foundation for the Blind, a body corporate constituted under the Royal New Zealand Foundation for the Blind Act 1963, gives notice that it intends to promote a private Bill under the short title of “The Royal New Zealand Foundation of the Blind Act 2002”.

The objects of the Bill are to:

(a) Clarify the foundation’s status as a body that is controlled primarily by, and operates for the benefit of, people who are blind and vision impaired;

(b) To modernise the foundation’s structure, giving it characteristics of an incorporated society;

(c) To provide for the possible future registration of the foundation as a society incorporated under the Incorporated Societies Act 1908.

The promoter of the Bill is the Royal New Zealand Foundation for the Blind.

Communication or notices to the promoter concerning the Bill may be sent to its solicitors:

Buddle Findlay, State Insurance Tower, 1 Willis Street (P.O. Box 2694), Wellington (Attention: T. J. Power).

A copy of the Bill may be inspected in accordance with the Standing Orders of the House of Representatives during office hours at:

(i) The District Court, 65-69 Albert Street, Auckland; or

(ii) The offices of Buddle Findlay, Barristers and Solicitors, State Insurance Tower, 1 Willis Street, Wellington.

JANE HOLDEN, Chief Executive.

pb1604

Departmental Notices

Agriculture and Forestry

Animal Products (Ancillary and Transitional Provisions) Act 1999

Approval for the Use of a Drug or Substance for the Prevention or Treatment of Disease in Bees
Notice No. 1229

Section 62 (1) of the Animal Products (Ancillary and Transitional Provisions) Act 1999, provides that:

“No person may use any drug, substance, or mixture of substances for the prevention or treatment of any disease in bees, other than a drug for the time being approved for that purpose pursuant to subsection (2).”

Section 62 (2) of the Animal Products (Ancillary and Transitional Provisions) Act 1999, provides that:

“The Minister may from time to time, by notice in the New Zealand Gazette, approve the use, subject to such conditions as the Minister specifies, of any specified drug for the prevention or treatment of any specified disease.”

Pursuant to section 62 of the Animal Products (Ancillary and Transitional Provisions) Act 1999, I approve the use of the compound “Oxalic Acid Dihydrate” for the prevention or treatment of varroa (Varroa Jacobsoni) subject to the following conditions:

• The product must be used in compliance with the Code of Practice for own use of substances approved under section 28 of the Agricultural Compounds and Veterinary Medicines Act 1997, and until such time as that Code is approved, in compliance with the Proposed Code of Practice for own use of substances published in the February 2002 edition of AgVetLink (a Ministry of Agriculture and Forestry publication).
• Use must be limited to periods when honey supers are not present on the hives.

Dated at Wellington this 6th day of March 2002.

PAUL SWAIN, for Jim Sutton, Minister of Agriculture.

go1615

Approval for the Use of a Drug or Substance for the Prevention or Treatment of Disease in Bees
Notice No. 1230

Section 62 (1) of the Animal Products (Ancillary and Transitional Provisions) Act 1999, provides that:

“No person may use any drug, substance, or mixture of substances for the prevention or treatment of any disease in bees, other than a drug for the time being approved for that purpose pursuant to subsection (2).”

Section 62 (2) of the Animal Products (Ancillary and Transitional Provisions) Act 1999, provides that:

“The Minister may from time to time, by notice in the New Zealand Gazette, approve the use, subject to such conditions as the Minister specifies, of any specified drug for the prevention or treatment of any specified disease.”

Pursuant to section 62 of the Animal Products (Ancillary and Transitional Provisions) Act 1999, I approve the use of the compound “Formic Acid 85%” for the prevention or treatment of varroa (Varroa Jacobsoni) subject to the following conditions:

• The product must be used in compliance with the Code of Practice for own use of substances approved under section 28 of the Agricultural Compounds and Veterinary Medicines Act 1997, and until such time